Table 2.
Patient and treatment characteristics
| Sex | Age (years) | TMN | CTx | Total dose (Gy) | Infield outcome | Recurrence | TTP (months) | OS (months) | Ref |
|---|---|---|---|---|---|---|---|---|---|
| Female | 61 | T3N2M0 | EP | 50.4 | SD | R | 11 | 15 > | [13] |
| Male | 56 | T3N1M0 | 5-FU | 58.4 | PR | L + R + DM | 5 | 8 | [13] |
| Male | 50 | T3N2M0 | EP | 50/4 | CR | No | – | 12 > | [13] |
T tumor, N node, M metastasis, CTx chemotherapy, EP etoposide and carboplatin, 5-FU 5-fluorouracil, SD stable disease, PR partial response, CR complete response, R regional recurrence, L local recurrence, DM distant metastasis, TTP time to progression, OS overall survival, Ref reference